Modifi Bio
Latest round
- Seed
Last raised
- Aug 2023
Total raised
- $11M
Investors
- 8
About Modifi Bio
a. Modifi Bio develops a new class of molecules, designed to be delivered orally to selectively kill cancer cells via direct cancer DNA modification., Inc. fully acquired Modifi Biosciences from BrightEdge Ventures, Connecticut Innovations, HighCape Partners, Ironwood Capital, National Brain Tumor Society, Pathway Bioventures, The Sontag Foundation, and Yale University for USD 30 million. The company provides oncology treatment therapeutics that target specific acquired cancer cell DNA mutations.
Who invested in Modifi Bio
8 investors across 2 rounds
See all investors in Modifi Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Modifi Bio
Who invested in Modifi Bio?
Modifi Bio has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Modifi Bio raised?
Modifi Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Modifi Bio last raise money?
Modifi Bio's most recent round on record is a Seed, in Aug 2023.
What does Modifi Bio do?
Modifi Bio is a biotechnology company.
Where is Modifi Bio headquartered?
Modifi Bio is headquartered in New Haven, US.
Which VCs invest in companies like Modifi Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Modifi Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Modifi Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.